大结节性结直肠病变内镜黏膜下剥离术中肌肉回缩征的患病率及临床意义(附视频)
这项前瞻性多中心研究纳入2017年1月至2022年10月两家学术中心因隆起性病变或>10 mm大结节颗粒混合型侧向发育型肿瘤接受内镜黏膜下剥离术的患者,评估肌肉回缩征(MRS)对技术及临床结局的影响。694处病变中84处(12%)存在MRS;MRS+组治愈性切除率41.6%低于MRS-组81.3%,穿孔率22.6%高于9.2%,黏膜下癌34.9%高于9.2%,手术率45.2%高于6%。MRS+结肠病变R0切除率53%低于直肠病变74.3%。
要点
- 694处病变中84处(12%)存在肌肉回缩征(MRS)。
- MRS+组治愈性切除率41.6%低于MRS-组81.3%,穿孔率22.6%高于9.2%,手术率45.2%高于6%。
- MRS+结肠病变R0切除率53%低于直肠病变74.3%。
核心结论
- MRS降低肿瘤学结局并增加穿孔率;作者认为结肠操作中检出MRS应停止,直肠操作应继续,因替代治疗存在并发症风险。
研究设计与样本
- 前瞻性纳入2017年1月至2022年10月两家学术中心因隆起性病变或>10 mm大结节颗粒混合型侧向发育型肿瘤接受ESD的患者,共694处病变;大结节大小回顾性分析。
主要发现
- 694处病变中84处(12%)存在MRS。
- 治愈性切除率MRS+组41.6% vs MRS-组81.3%。
- 穿孔率MRS+组22.6% vs MRS-组9.2%,黏膜下癌率MRS+组34.9% vs MRS-组9.2%,手术率MRS+组45.2% vs MRS-组6%。
- MRS+结肠病变R0切除率53% vs 直肠病变74.3%。
- 多因素分析显示隆起性病变(OR 2.47,95%CI 1.27-4.80)和大结节>4 cm(OR 4.24,95%CI 2.23-8.05)是MRS的危险因素。
关键数值与推荐
- MRS+组治愈性切除率41.6%,MRS-组81.3%。
- MRS+组穿孔率22.6%,MRS-组9.2%。
- MRS+组黏膜下癌率34.9%,MRS-组9.2%。
- MRS+组手术率45.2%,MRS-组6%。
- MRS+结肠病变R0切除率53%,直肠病变74.3%。
临床怎么用
- 作者认为结肠操作中检出MRS应停止,直肠操作应继续,因替代治疗存在并发症风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The muscle retracting sign (MRS) can be present during endoscopic submucosal dissection (ESD) of macronodular colorectal lesions. The prevalence of MRS and its pathologic and clinical implications is unclear. This study evaluated the effect of MRS on the technical and clinical outcomes of ESD. METHODS: All patients referred for ESD of protruding lesions or granular mixed lesions with >10 mm macronodule granular mixed laterally spreading tumors (LST-GMs) in 2 academic centers from January 2017 to October 2022 were prospectively included. Size of the macronodule was analyzed retrospectively. The primary outcome was the curative resection rate according to MRS status. Secondary outcomes were R0 resection, perforation, secondary surgery rate, and risk factors for MRS. RESULTS: Of 694 lesions, 84 (12%) had MRS (MRS+). The curative resection rate was decreased by MRS (MRS+ 41.6% vs lesions without MRS [MRS-] 81.3%), whereas the perforation (MRS+ 22.6% vs MRS- 9.2%), submucosal cancer (MRS+ 34.9% vs MRS- 9.2%), and surgery (MRS+ 45.2% vs MRS- 6%) rates were increased. The R0 resection rate of MRS+ colonic lesions was lower than that of rectal lesions (53% vs 74.3%). In multivariate analysis, protruding lesions (odds ratio, 2.47; 95% confidence interval, 1.27-4.80) and macronodules >4 cm (odds ratio, 4.24; 95% confidence interval, 2.23-8.05) were risk factors for MRS. CONCLUSIONS: MRS reduces oncologic outcomes and increases the perforation rate. Consequently, procedures in the colon should be stopped if MRS is detected, and those in the rectum should be continued due to the morbidity of alternative therapy.
引用
- Albouys J, Manzah I, Schaefer M, et al. Prevalence and clinical significance of the muscle retracting sign during endoscopic submucosal dissection of large macronodular colorectal lesions (with videos). Gastrointest Endosc. 2023. PMID: 37866709. doi:10.1016/j.gie.2023.10.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。